{"id":57665,"date":"2026-08-05T12:29:32","date_gmt":"2026-08-05T12:29:32","guid":{"rendered":"https:\/\/www.bridge-global.com\/blog\/?p=57665"},"modified":"2026-08-07T12:39:02","modified_gmt":"2026-08-07T12:39:02","slug":"clinical-ai-copilots-build-and-scale","status":"publish","type":"post","link":"https:\/\/www.bridge-global.com\/blog\/clinical-ai-copilots-build-and-scale\/","title":{"rendered":"Clinical AI Copilots: A Build &#038; Scale Guide"},"content":{"rendered":"<p>You&#039;re in the room with a patient, the clock is tight, the chart is already behind, and the next click could either save ten minutes or create another cleanup task for later. That&#039;s the true test for clinical AI copilots. They&#039;re only useful when they fit the visit, support the clinician&#039;s judgment, and leave behind a note, recommendation, or message that can survive review without turning into another documentation burden.<\/p>\n<p>That&#039;s why the conversation has moved past glossy demos. In practice, teams need to know which workflows a copilot can credibly support, where it creates new verification work, what data and compliance boundaries apply, and how to move from a promising pilot to something clinicians trust. If you&#039;re also thinking through the surrounding care model, a useful companion read is <a href=\"https:\/\/weightmethod.com\/blog\/is-telehealth-a-video-call\" target=\"_blank\" rel=\"noopener\">understanding virtual care options<\/a>, because the same questions about workflow, access, and user experience show up there too.<\/p>\n<h2>The Moment a Copilot Steps Into a Clinical Visit<\/h2>\n<p>A primary care clinician opens a visit, listens to a patient describe fatigue, medication changes, and a recent urgent care trip, and the ambient copilot drafts the note in the background. It flags a possible medication issue, surfaces a follow-up reminder, and prepares a patient message for after the encounter. The clinician still owns every call, but the visit changes because the system is doing real work instead of sitting idle.<\/p>\n<p>That promise is also where the first hard questions start. Did the copilot capture the right clinical nuance, or did it flatten the story into generic text? Did it create new review burden by generating too much, too loosely, or too confidently? If it suggests a next step, who is accountable when the suggestion is wrong?<\/p>\n<blockquote>\n<p><strong>Practical rule:<\/strong> if the clinician cannot review, edit, and reject the draft inside the same workflow, the copilot is not reducing friction; it is moving it.<\/p>\n<\/blockquote>\n<p>The boundary matters because not every setting deserves the same level of automation. Ambient documentation, evidence surfacing, and follow-up drafting fit well when the output stays inside the clinician&#039;s normal path. Fully autonomous triage is a different category, with higher verification, regulatory, and liability pressure.<\/p>\n<p>The market has already crossed the experimentation line. The <a href=\"https:\/\/www.ama-assn.org\/practice-management\/digital-health\/2-3-physicians-are-using-health-ai-78-2023\" target=\"_blank\" rel=\"noopener\">American Medical Association reported<\/a> that 66% of physicians were using health AI in 2024, up 78% from 2023, and 10% reported using patient-facing chatbots for customer-service functions. For teams comparing ambient documentation approaches, <a href=\"https:\/\/www.bridge-global.com\/blog\/ambient-clinical-intelligence-guide\/\">this guide to ambient clinical intelligence<\/a> helps frame where speech capture, transcription quality, and workflow design start to matter in real use. That does not mean every AI feature works in the clinic, but it does mean clinical AI is no longer a side project.<\/p>\n<p>For teams building in this space, the first job is not adding AI. It is deciding where a copilot belongs in the care flow, where it makes clinicians faster, and where it makes them slower. The difference decides whether the system becomes daily infrastructure or another abandoned pilot.<\/p>\n<h2>What Clinical AI Copilots Actually Are<\/h2>\n<p><figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/08\/clinical-ai-copilots-clinical-ai.jpg\" alt=\"A diagram illustrating three high-value clinical AI use cases for healthcare: ambient documentation, decision support, and treatment plans.\" \/><\/figure>\n<\/p>\n<p>A clinical AI copilot is not a chatbot with a medical vocabulary and a nicer UI. It&#039;s a role-aware, human-in-the-loop assistant that drafts documentation, surfaces evidence, or recommends next steps for a licensed clinician to review. Think of it less like an oracle and more like a senior resident who never sleeps, drafts everything for sign-off, and never signs the note.<\/p>\n<h3>The core pattern<\/h3>\n<p>The workflow usually starts with speech capture, then medical-domain speech-to-text, then clinical concept extraction, then retrieval over the right evidence, and finally human-approved output. That structure is not cosmetic. A multi-stage ambient documentation pipeline, as described in the research brief, is built to turn audio into structured note-ready output such as JSON, CDA, or FHIR.<\/p>\n<p>The transcription layer matters more than product teams often admit. Medical conversations are packed with names, abbreviations, drug terms, and weirdly spoken numbers, so generic transcription stacks can create avoidable cleanup work. Domain-tuned models like Whisper v3 or Deepgram&#039;s Nova Medical are used because the point is not perfect prose; it&#039;s lowering downstream editing and coding mistakes.<\/p>\n<p>A copilot also needs to behave differently from adjacent tools. Clinical decision support tends to surface evidence or alerts. AI scribes focus on note capture. A copilot should do both, but only inside a workflow where the clinician remains the final decision-maker.<\/p>\n<blockquote>\n<p>The label matters less than the operating model. If the system acts without review, it&#039;s automation. If it drafts for review and keeps traceability intact, it&#039;s a copilot.<\/p>\n<\/blockquote>\n<p>For a practical comparison with adjacent decision support patterns, <a href=\"https:\/\/www.bridge-global.com\/blog\/ai-driven-clinical-decision-support\/\">our guide to AI-driven clinical decision support<\/a> helps separate evidence surfacing from broader copilot behavior. That distinction is useful when you&#039;re deciding what to build first, because not every healthtech feature needs the full copilot stack on day one.<\/p>\n<h2>Clinical Use Cases Worth Building First<\/h2>\n<p><figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/08\/clinical-ai-copilots-production-architecture.jpg\" alt=\"A diagram illustrating a four-step production-grade architecture for clinical AI copilots, including audio capture, transcription, and extraction.\" \/><\/figure>\n<\/p>\n<p>The strongest early use cases are the ones where the copilot saves attention without deciding anything on its own. Ambient documentation is the obvious one, but it&#039;s only the first of three that consistently show up in successful deployments. The other two are point-of-care evidence surfacing and care-coordination drafting.<\/p>\n<h3>Ambient documentation during the encounter<\/h3>\n<p>This is the most mature starting point because the value is visible immediately. The copilot listens, drafts the note, and organizes the encounter into a cleaner clinical structure. The clinician still verifies the content, but they&#039;re not starting from a blank page.<\/p>\n<p>That said, ambient notes are not free. If the model misses a medication change, incorrectly attributes a symptom, or captures the wrong chronology, the clinician ends up re-reading like an editor instead of signing like a reviewer. In pilots, this is the point at which teams discover that \u201ctime saved\u201d can disappear into trust-building and correction work.<\/p>\n<h3>Decision support at the point of care<\/h3>\n<p>This use case is narrower and often more valuable than people expect. The copilot can pull in guideline snippets, patient context, or prior history and present evidence that supports a decision. The right goal is not to replace clinical reasoning. It&#039;s to reduce the time spent hunting for the next useful fact.<\/p>\n<p>A production-grade version should be retrieval-grounded, not free-form. Microsoft&#039;s healthcare guidance describes grounded responses from customer-owned sources, healthcare intelligence sources like NIH\/FDA content, and safeguards that check for evidence, hallucinations, and omissions in high-stakes settings. That design is the difference between a useful assistant and a risky text generator. For a deeper view of the integration layer behind those workflows, <a href=\"https:\/\/www.bridge-global.com\/blog\/healthcare-integration-architecture\/\">the healthcare integration architecture guide<\/a> is a helpful companion.<\/p>\n<h3>Care coordination and follow-up drafting<\/h3>\n<p>This is the least glamorous use case, and often the one clinicians keep using. The copilot can summarize a referral, draft an after-visit message, or turn a messy thread into a cleaner handoff. It&#039;s especially useful when the output is short, bounded, and easy to verify.<\/p>\n<p>A lower-fit use case is autonomous triage. The verification burden is heavier, the clinical risk is higher, and the accountability questions get messy fast. If the system&#039;s job is to suggest, it can help. If its job is to decide, the bar jumps sharply.<\/p>\n<h2>Architecture and Integration Patterns That Hold Up in Production<\/h2>\n<p><figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/08\/clinical-ai-copilots-safety-controls.jpg\" alt=\"An infographic detailing four mandatory data and safety controls for clinical AI, including HIPAA compliance and human review.\" \/><\/figure>\n<\/p>\n<p>Production behavior starts with architecture, not prompt tuning. A clinical copilot that works in a demo can still fail once it meets the pace of a real visit, a noisy note stream, and an EHR that was never designed for model outputs. The pattern that holds up is a layered pipeline that turns raw encounter data into something a clinician can verify quickly. The research brief describes the flow as real-time audio capture, speech-to-text, LLM-based clinical concept extraction, and structured note generation into EHR-ready outputs such as JSON, CDA, or FHIR.<\/p>\n<h3>What the stack actually needs to do<\/h3>\n<p>The audio layer has to be low-friction and stable. If it drops words, the rest of the stack spends the visit recovering from avoidable errors. The transcription layer needs medical vocabulary support, and the extraction layer needs to identify concepts, not just rewrite text. The output layer has to fit the clinician&#039;s existing interface, because even a strong model fails when the write-back path is clumsy.<\/p>\n<p>Integration is where many vendor demos collapse. Teams need SSO, role mapping, EHR write-back, queueing for human review, and observability hooks. Those are not nice-to-have extras. They are the mechanics that make the copilot usable inside a real hospital system, and they only work if the workflow matches how clinicians already move through charting, sign-off, and follow-up.<\/p>\n<h3>Why retrieval and grounding matter more than fancy prompts<\/h3>\n<p>The best clinical copilots do not answer from memory. They ground responses in patient history, source documents, and trusted clinical references. Microsoft&#039;s healthcare guidance explicitly points to grounded answers from customer-owned sources, healthcare intelligence sources like NIH and FDA content, and safeguards that inspect evidence quality and missing context. A useful companion for the integration layer behind those workflows is <a href=\"https:\/\/www.bridge-global.com\/blog\/healthcare-integration-architecture\/\">the healthcare integration architecture guide<\/a>.<\/p>\n<p>Prompt engineering alone will not carry the product. If the model is asked to summarize a medication plan, it needs access to the right note fragment, the right guideline, and the right output constraints. Otherwise, the system can produce polished language that looks confident but is not verifiable. In production, that is where pilots stall, because the team discovers that the hard part is not getting a draft on screen; it is making the draft traceable enough for clinical review.<\/p>\n<h3>The integration work vendors downplay<\/h3>\n<p>Here is the work healthtech teams usually inherit after the pilot. They must map fields into EHR resources, align user roles with permissions, and handle exceptions when the draft cannot be trusted. They also need auditing for every model run and every clinician action, because once the note enters the record, traceability is what keeps the system defensible.<\/p>\n<p>Teams that need both product and platform support often need <a href=\"https:\/\/www.bridge-global.com\/healthcare\">custom healthcare software development<\/a> to build the workflow, integration, and governance pieces together instead of treating them as separate projects. The value is not in a flashy model layer. It is in the plumbing between systems, the controls around handoff, and the discipline to keep the copilot inside the boundaries clinicians can review, correct, and trust.<\/p>\n<h2>Data, Privacy, and Safety Controls You Cannot Skip<\/h2>\n<p>Clinical AI copilots should treat safety controls like product features, not legal footnotes. If those controls are bolted on later, the workflow usually becomes harder to trust, harder to audit, and harder to scale. The minimum bar is simple to state and difficult to fake: protect PHI, preserve accountability, and make every recommendation traceable.<\/p>\n<h3>The essentials<\/h3>\n<p>A copilot needs audit logging of model inference, rendered output, and clinician actions. One healthcare-focused explanation of copilots says the clinician must review and approve the draft before it enters the medical record, and it also calls out audit logs as a production requirement. That is not a compliance extra; it is how you preserve accountability when a note is challenged later.<\/p>\n<p>It also needs citation-grounded outputs. A source-verified clinical AI framework explicitly says each claim in the model output should link back to source material through inline citations or reference IDs, so reviewers can trace the recommendation to supporting evidence. In day-to-day use, that means the draft should show which note fragment, guideline paragraph, or source document supports each statement.<\/p>\n<blockquote>\n<p>If a clinician can&#039;t trace a statement back to evidence in seconds, verification becomes a second job.<\/p>\n<\/blockquote>\n<h3>What to require before launch<\/h3>\n<ul>\n<li>\n<p><strong>Role-based access control:<\/strong> Make sure the copilot only sees and edits what the user is authorized to handle.<\/p>\n<\/li>\n<li>\n<p><strong>Tenant isolation:<\/strong> Keep patient data separated across organizations and environments.<\/p>\n<\/li>\n<li>\n<p><strong>Human-in-the-loop sign-off:<\/strong> Require clinician approval before anything lands in the chart.<\/p>\n<\/li>\n<li>\n<p><strong>Auditability end to end:<\/strong> Log inputs, model outputs, edits, and final submissions.<\/p>\n<\/li>\n<li>\n<p><strong>Grounded responses only:<\/strong> Keep free-form generation out of high-stakes recommendation paths.<\/p>\n<\/li>\n<\/ul>\n<p>These controls matter in <a href=\"https:\/\/www.bridge-global.com\/services\/custom-software-development\">custom software development<\/a> programs, because the governance model has to be designed into the product rather than patched on afterward. The integration team, security team, and clinical leads also need the same artifact set, not three separate interpretations of what safe enough means.<\/p>\n<h2>Measuring Whether the Copilot Helps<\/h2>\n<p>If the only metric is \u201cpeople like it,\u201d the rollout is probably premature. Clinical copilots need operational measurements that reflect both speed and correctness. The useful ones are note-writing time, clinician-reported cognitive load, override rates, error rates against gold-standard review, and downstream coding accuracy.<\/p>\n<h3>The signal in the data<\/h3>\n<p>The evidence says the gains are real, but usually modest. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12973079\" target=\"_blank\" rel=\"noopener\">A 2025 systematic review in PMC found<\/a> that most ambient documentation tools reduced documentation time by about 1 to 2.1 minutes per note. The same review also reported usability and satisfaction improvements, while noting accuracy problems from omission and hallucination in simulated testing.<\/p>\n<p>A separate quality-improvement study of 46 clinicians using Nuance DAX Copilot reported a 20.4% decrease in note-writing time per visit, from 10.3 to 8.2 minutes with P&lt;0.001. That&#039;s a useful benchmark, but it&#039;s not a guarantee. In real deployments, the gains vary by specialty, encounter type, and how much cleanup the clinician still has to do.<\/p>\n<p>The other meaningful result comes from clinician-AI collaboration design. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12155023\" target=\"_blank\" rel=\"noopener\">In a randomized controlled trial, clinicians using AI-assisted workflows reached<\/a> average accuracies of 85% when the AI was used first and 82% when it was used second, compared with 75% using traditional resources alone, with mean differences of 9.8% and 6.8%. Workflow order matters because the copilot changes how people reason, not just how fast they type.<\/p>\n\n\n<figure class=\"wp-block-table\"><table><tr>\n<th>Metric<\/th>\n<th>What it measures<\/th>\n<th>How to collect it<\/th>\n<\/tr>\n<tr>\n<td>Documentation time per note<\/td>\n<td>Time spent creating or finalizing the note<\/td>\n<td>Timestamped workflow telemetry, time-motion sampling<\/td>\n<\/tr>\n<tr>\n<td>Cognitive load<\/td>\n<td>How mentally expensive the workflow feels<\/td>\n<td>Clinician surveys and structured feedback<\/td>\n<\/tr>\n<tr>\n<td>Error rate<\/td>\n<td>Mismatches between draft and gold-standard review<\/td>\n<td>Chart audits, reviewer comparison<\/td>\n<\/tr>\n<tr>\n<td>Override rate<\/td>\n<td>How often clinicians reject or heavily rewrite suggestions<\/td>\n<td>Edit logs and approval logs<\/td>\n<\/tr>\n<tr>\n<td>Coding accuracy<\/td>\n<td>Whether the note supports correct coding<\/td>\n<td>Post-visit coding review and billing audits<\/td>\n<\/tr>\n<\/table><\/figure>\n\n\n<p>That table is the right starting set because it separates perceived convenience from real clinical utility. A copilot that is liked but heavily rewritten is still a weak product. A copilot that saves less time but improves accuracy and reduces rework can be the stronger system.<\/p>\n<h2>From Proof of Concept to Scaled Rollout<\/h2>\n<p>A pilot that works in a demo room can still fail on the ward. The safest rollout pattern is narrow first, broader later. Pick one workflow, one clinician group, and one success definition. If you start with too many specialties or too many output types, you&#8217;ll spend the pilot proving that different teams want different things.<\/p>\n<h3>Phase one: Prove one workflow<\/h3>\n<p>The first version should handle a bounded use case, usually ambient documentation or a tightly scoped decision-support task. The point is to prove that the copilot fits the actual workflow, not a demo workflow built to flatter the model. Success should be measured in review time, edit burden, and clinician trust, not just model output quality.<\/p>\n<p>A pilot also needs a clear boundary for what the system will not do. If the copilot starts drafting outside its scope, the team should be able to spot it quickly, review the failure, and keep the workflow moving without extra manual cleanup. That discipline matters more than broad feature coverage at the start.<\/p>\n<h3>Phase two: Add governance before scope<\/h3>\n<p>Once the pilot works, the governance questions get louder. Who approves model changes? Who reviews errors? What gets logged? What happens when the copilot is wrong in a way that affects care coordination or billing?<\/p>\n<p>A formal AI implementation roadmap helps when it is tied to release gates, monitoring, and change-management work rather than just a feature backlog. Teams that already work with <a href=\"https:\/\/www.bridge-global.com\/services\/artificial-intelligence-development\">AI development services<\/a> can move faster here, but only if the roadmap includes clinician validation and rollback plans.<\/p>\n<p>Governance also has to cover auditability in plain terms. If an output was used, reviewed, edited, or rejected, the record should show that clearly enough for clinical review, billing review, and incident follow-up. Without that trail, pilot results are hard to trust and harder to operationalize.<\/p>\n<h3>Phase three: Scale carefully<\/h3>\n<p>Scaling means more than turning on another department. It means more roles, more note types, more edge cases, and more integration maintenance. It also means more opportunities for trust to break if the system starts producing bad drafts or unclear recommendations.<\/p>\n<p>The hidden costs show up quickly. Verification workload grows when the model is overly verbose. Integration maintenance grows when EHR workflows shift. Clinician trust takes time to rebuild after a bad output, even if the next release is better.<\/p>\n<p>If the product is intended to become part of a broader platform, the rollout should be designed like a product line, not a one-off feature. That calls for <a href=\"https:\/\/www.bridge-global.com\/services\/saas-solutions\">SaaS product development<\/a> thinking as well as durable software practices, because clinical copilots have to hold up under repeated releases, audits, and workflow changes.<\/p>\n<h2>Choosing Partners, Managing Change, and Proving ROI<\/h2>\n<p>The partner decision should rest on clinical evidence, integration depth, and safety architecture, not on who delivers the smoothest demo. If a vendor cannot support <a href=\"https:\/\/www.bridge-global.com\/healthcare\/tools-and-integrations\">healthcare integrations<\/a>, the copilot will hit a ceiling fast. If the team behind it cannot support the AI layer, the product roadmap can stall as soon as the workflow meets real clinical constraints.<\/p>\n<h3>What to look for in a partner<\/h3>\n<ul>\n<li>\n<p><strong>Clinical workflow understanding:<\/strong> They should know how notes, orders, and follow-up move through daily practice.<\/p>\n<\/li>\n<li>\n<p><strong>Safety design:<\/strong> They should support grounded outputs, audit trails, and human review.<\/p>\n<\/li>\n<li>\n<p><strong>Integration capability:<\/strong> They should handle EHR connectivity and the operational limits of the environment.<\/p>\n<\/li>\n<li>\n<p><strong>Operating model fit:<\/strong> They should work in a way that matches your release cadence and governance.<\/p>\n<\/li>\n<\/ul>\n<p>Change management matters just as much. Clinician champions need to explain that copilots are there to support judgment, not replace it. Training should focus on review habits, exception handling, and when to reject the draft outright.<\/p>\n<p>The rollout also needs a clear story for the people using it every day. If clinicians do not trust the draft, they will work around it, and the tool becomes one more screen to close. Early sessions should give teams space to test edge cases, surface failure modes, and agree on what the copilot is allowed to say.<\/p>\n<p>For ROI, the cleanest case is usually reduced documentation burden, better workflow consistency, and fewer downstream corrections. If you need a broader framing for the business case, <a href=\"https:\/\/www.bridge-global.com\/ai-advantage\">enterprise AI solutions<\/a> are the right lens, because these systems have to fit into revenue, operations, and compliance together. Good examples in <a href=\"https:\/\/www.bridge-global.com\/client-cases\">client cases<\/a> usually show the same pattern: a narrow use case, a measured rollout, and a partner model that keeps delivery aligned with clinical reality.<\/p>\n<p>The engagement model matters too. <a href=\"https:\/\/www.bridge-global.com\/service-models\">Software development service models<\/a> that allow for discovery, iterative delivery, and ongoing support tend to fit clinical copilots better than fixed-scope builds. The product changes as clinicians use it, and the partnership has to absorb that reality.<\/p><!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>You&#039;re in the room with a patient, the clock is tight, the chart is already behind, and the next click could either save ten minutes or create another cleanup task for later. That&#039;s the true test for clinical AI copilots. &hellip;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":83,"featured_media":57664,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1015],"tags":[1077,1365,1723,1830,1831],"class_list":["post-57665","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","tag-healthtech-ai","tag-healthcare-automation","tag-clinical-decision-support","tag-clinical-ai-copilots","tag-hipaa-ai"],"featured_image_src":"https:\/\/www.bridge-global.com\/blog\/wp-content\/uploads\/2026\/08\/clinical-ai-copilots-medical-hologram.jpg","author_info":{"display_name":"Preethi Saro Philip","author_link":"https:\/\/www.bridge-global.com\/blog\/author\/preethi\/"},"_links":{"self":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/57665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/users\/83"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/comments?post=57665"}],"version-history":[{"count":2,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/57665\/revisions"}],"predecessor-version":[{"id":57671,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/posts\/57665\/revisions\/57671"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/media\/57664"}],"wp:attachment":[{"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/media?parent=57665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/categories?post=57665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bridge-global.com\/blog\/wp-json\/wp\/v2\/tags?post=57665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}